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Supplementary data: Supplementary data including experimental procedures and characterization of resins with IR and final compounds with NMR, high-resolution mass spectrometry, and quantitative phosphorus analysis, enzyme assay procedures can be found in the online version of this article. include the reactions of methylene diphosphonic acids with nucleoside 5′-monophosphates, 9, 10 5′-monophosphate-N-methylimidazolides, 11, 12 or 5′-monophosphate-imidazolides 13 . Alternatively, sequential Michael-Arbuzov reactions on ethyl(bishalomethyl) phosphinates 8 were used for the synthesis of the bismethylene triphosphates. These synthetic strategies analogs have been encountered by one or more of the following difficulties. (i) Activated nucleoside monophosphates or their specific salt forms are required for the synthesis of 5′-O-β,γ-methylenetriphosphate nucleoside analogs, respectively. (ii) The coupling reactions are mostly carried out in anhydrous organic solvents. Because of the poor solubility of most precursor phosphates in the reaction mixture, the yields are usually low. (iii) Stepwise lengthy purification of intermediates and final products from the reagents are required. (iv) These strategies require protection and deprotection reactions for most of nucleosides. Thus, alternative convenient strategies for the preparation of 5′-O-β,γ-methylenenucleoside triphosphates are highly desired.
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Herein, we report for the first time a solid-phase strategy for the synthesis of β,γ-methylenetriphosphate nucleoside analogs by using a novel solid-supported phosphitylating reagent. A β,γ-methylenetriphosphitylating reagent was prepared first. Aminomethyl polystyrene resin-bound linker of p-acetoxybenzyl alcohol 14 was used as solid support for immobilization of β,γ-methylenetriphosphitylating reagent. The unprotected nucleosides were reacted with the immobilized reagent. Subsequent oxidation, deprotection, and cleavage afforded the β,γ-methylenetriphosphate nucleoside analogs.
Scheme 1 illustrates the synthesis of β,γ-methylenetriphosphitylating reagent 6. Phosphorus trichloride (1, 6 mmol) was reacted with diisopropylamine (2 equiv) to yield bis In a separate reaction, bis(dichlorophosphino)methane 4 (6 mmol) was treated with 3-hydroxypropionitrile (3 equiv) to yield 5, which was reacted with 3 (1 equiv) to yield β,γ-methylenetriphosphitylating reagent (6) . The chemical structure of 6 was confirmed by highresolution time-of-flight electrospray mass spectrometry (ESI-TOF) and elemental phosphorus analysis. Compound 6 was immediately used for the next coupling reaction with polymerbound p-acetoxybenzyl alcohol 7 to avoid any decomposition.
Aminomethyl polystyrene resin-bound linker of p-acetoxybenzyl alcohol (7) was synthesized from aminomethyl polystyrene resin in multiple-step reactions 14 and was selected as a solid support for immobilization of the β,γ-methylenetriphosphitylating reagent. We have previously reported the application of the p-acetoxybenzyl alcohol linkers for the solid-phase synthesis of diverse number of compounds, such as carbohydrate and nucleoside monophosphates, [15] [16] [17] diphosphates, diphosphodithioates, triphosphates, or triphosphotrithioates, 18 nucleoside β-triphosphates, 19 oligodeoxynucleotides containing internucleotide diphosphodiester linkages, 20 sulfonamides, 14 symmetrical 5′,5′-dinucleoside mono-, di-, tri-, and tetraphosphodiesters, 21 and nucleoside 5′-O-α,β-methylene-β-triphosphates 22 .
Scheme 2 shows the synthesis of nucleoside α,β-and β,γ-methylenetriphosphates. Polymerbound linker 7 was reacted with β,γ-methylenetriphosphitylating reagent (6, 1.2 equiv) in the presence of 5-(ethylthio)-1H-tetrazole to produce the corresponding polymer-bound β,γ-methylenetriphosphitylating reagent 8. The treatment of unprotected nucleosides (4 mmol, e.g., adenosine (a), 3′-azido-3′-deoxythymidine (b), thymidine (c), cytidine (d), and inosine (e)) with 8 (1 mmol) in the presence of 5-(ethylthio)-1H-tetrazole gave 9a-e, respectively. Oxidation with tert-butyl hydroperoxide followed by removal of the cyanoethoxy group with DBU, afforded the corresponding polymer-bound nucleoside β,γ-methylenetriphosphates, 11a-e. Subsequent steps were supported by FT-IR peaks for all the intermediate resins. Among all the synthesized methylenetriphosphate derivatives, 14d is a novel compound. Adenosine, cytidine, and inosine contain a secondary (2′ and/or 3′) alcohol, a primary (5′) alcohol, or a free amino group. Only 5′-O-substituted compounds were purified with high selectivity as a result of this sequence. The presence of the phosphitylating reagents on the solid support having a hindered structure allowed for the regioselective reaction of the unprotected nucleosides with the polymer-bound phosphitylating reagents. There was no need to protect the free aromatic amino group in adenosine and cytidine. The most reactive hydroxyl group of unprotected nucleosides reacted selectively with hindered and bulky polymer-bound reagents when an excess of nucleoside was used. The compounds were characterized by 1 H NMR, 13 C NMR, 31 P NMR, ESI-TOF, and phosphorus elemental analysis.
Nucleoside methylenetriphosphates remain attractive probes and nonhydrolyzable triphosphate mimics in studying and inhibiting the phosphate transfer in biological systems. The synthesized compounds were evaluated to determine whether they can inhibit human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), a critical enzyme in HIV life cycle.
HIV-1 RT converts the single-stranded RNA genome into double-stranded DNA that is later integrated into the host genome. 23 Retroviral RT's are multifunctional enzymes possessing DNA polymerase activities on both DNA and RNA templates, as well as a ribonuclease H (RNase H) activity that hydrolyzes the RNA of RNA/DNA replication intermediates. HIV-1 RT is a heterodimer consisting of p66 and p51 subunits that share the same sequence at the Nterminus. The RNase H domain resides in the C-terminus of p66 subunit, which is not present in p51. 24 Both DNA polymerase and RNase H activities of HIV-1 RT have been considered as potential targets for antiretroviral therapy. However, all currently used HIV-1 RT inhibitors are directed against the polymerase function of the enzyme. 25 Designing compounds that block the RNase H activity of the HIV-1 RT have been challenging. Although recent screening efforts led to the discovery of few RNase H inhibitors, none of them advanced into clinical trials. RNase H has been a challenging target for a number of reasons. Inhibitors that block the RTassociated RNase H function have higher cytotoxicity, since they interfere with the functions of cellular counterparts. RNase H proteins, including human RNase H, are homologous and share a similar three-dimensional fold. To address these challenges and to discovery of potent RNase H inhibitors we examined the potency of synthesized modified nucleoside analogs against RNase H and polymerase function of HIV-1 RT.
Initially we evaluated the potency of the compounds with modified phosphates towards the RNase H activity of HIV-1 RT at a fixed concentration (1 mM) of the compounds. RNase H assay was performed using recombinant RT and RNA/DNA hybrids as previously described [26] [27] [28] . The results of the RNase H cleavage are presented in Figure 1A . Lane W represents the RNase H cleavage products in the absence of any inhibitor. Lanes a-e represent the RNase H cleavage products in the presence of the compounds 14a-e, respectively. These results indicate that the RNase H activity of HIV-1 RT is inhibited by the cytidine derivative 14d (lane 4). Therefore, we tested the potency of compound 14d by performing concentration dependent inhibition assays. RNase H inhibition was not observed up to 100 μM with the compound. The results from 100 μM-1 mM are presented in Figure 1B . Compound 14d achieved complete inhibition of the RNase H activity at 700 μM ( Figure 1B, lane 6) . These results are consistent with our earlier studies that showed another modified nucleoside triphosphate derivative, cytidine 5′-O-α,β-methylene-β-triphosphate inhibited RNase H activity of HIV-1 reverse transcriptase. 22 We have also tested the potency of these compounds against the polymerase function of HIV-1 RT (Figure 2 ). In comparison to the wild type enzyme (lane w), the polymerase activity was not affected in the presence of the compound 14 a-e, (lanes a-e). However, compound 14c caused the polymerase complex to pause several positions during DNA synthesis (lane c). Since compound 14d did not inhibit the polymerase activity of HIV-1 RT (lane 4), it can provide insights for designing of additional compounds, which may have better inhibitory activity against the RNase H activity.
To the best of our knowledge, this is the first report of the synthesis of nucleoside β,γ-methylenetriphosphates by using solid-phase reagents without the need for precursors, such as nucleoside monophosphates or 5′-methylenediphosphonate analogs. Unreacted reagents were removed by extensive washing of the resins in each step. This solid-phase strategy offered the advantages of expeditious synthesis, 5′-O-substitution, high selectivity, facile isolation and purification of final products.
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Scheme 1.
Synthesis of β,γ-methylenetriphosphitylating reagent 6.
Scheme 2.
Synthesis of nucleoside 5′-O-β,γ-methylenetriphosphates 14a-e using polymer-bound reagent 8.
